CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $870,534 | +1924.5% | 207,270 | +2691.1% | 0.00% | – |
| Q3 2022 | $43,000 | +22.9% | 7,426 | +26.9% | 0.00% | – |
| Q2 2022 | $35,000 | +1650.0% | 5,851 | +1070.2% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 500 | -3.3% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 517 | +0.2% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 516 | -5.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 543 | +44.0% | 0.00% | – |
| Q1 2021 | $1,000 | -99.4% | 377 | -99.2% | 0.00% | – |
| Q4 2020 | $157,000 | +15600.0% | 48,910 | +13954.6% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 348 | -42.8% | 0.00% | – |
| Q2 2020 | $1,000 | – | 608 | +35.1% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 450 | -81.4% | 0.00% | – |
| Q2 2019 | $2,000 | -98.6% | 2,425 | -98.3% | 0.00% | – |
| Q1 2019 | $138,000 | +20.0% | 143,099 | -9.0% | 0.00% | – |
| Q4 2018 | $115,000 | -2.5% | 157,169 | +188.0% | 0.00% | – |
| Q3 2018 | $118,000 | -55.5% | 54,564 | +2.5% | 0.00% | – |
| Q2 2018 | $265,000 | +138.7% | 53,229 | +88.3% | 0.00% | – |
| Q1 2018 | $111,000 | +48.0% | 28,263 | +0.8% | 0.00% | – |
| Q4 2017 | $75,000 | – | 28,032 | +121778.3% | 0.00% | – |
| Q2 2017 | $0 | – | 23 | -8.0% | 0.00% | – |
| Q1 2017 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|